Eliminating the breast cancer surgery paradigm after neoadjuvant systemic therapy: current evidence and future challenges
In patients with operable early breast cancer, neoadjuvant systemic treatment (NST) is a standard approach. Indications have expanded from downstaging of locally advanced breast cancer to facilitate breast conservation, to in vivo drug-sensitivity testing. The pattern of response to NST is used to t...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
6 January 2020
|
| In: |
Annals of oncology
Year: 2020, Volume: 31, Issue: 1, Pages: 61-71 |
| ISSN: | 1569-8041 |
| DOI: | 10.1016/j.annonc.2019.10.012 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.annonc.2019.10.012 Verlag, lizenzpflichtig, Volltext: http://www.sciencedirect.com/science/article/pii/S0923753419354675 
|
| Author Notes: | J. Heil, H.M. Kuerer, A. Pfob, G. Rauch, H.P. Sinn, M. Golatta, G.J. Liefers & M.J. Vrancken Peeters |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1693627698 | ||
| 003 | DE-627 | ||
| 005 | 20240405193210.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 200331s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.annonc.2019.10.012 |2 doi | |
| 035 | |a (DE-627)1693627698 | ||
| 035 | |a (DE-599)KXP1693627698 | ||
| 035 | |a (OCoLC)1341311731 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Heil, Jörg |d 1978- |e VerfasserIn |0 (DE-588)132580187 |0 (DE-627)52396160X |0 (DE-576)299238679 |4 aut | |
| 245 | 1 | 0 | |a Eliminating the breast cancer surgery paradigm after neoadjuvant systemic therapy |b current evidence and future challenges |c J. Heil, H.M. Kuerer, A. Pfob, G. Rauch, H.P. Sinn, M. Golatta, G.J. Liefers & M.J. Vrancken Peeters |
| 264 | 1 | |c 6 January 2020 | |
| 300 | |a 11 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 31.03.2020 | ||
| 520 | |a In patients with operable early breast cancer, neoadjuvant systemic treatment (NST) is a standard approach. Indications have expanded from downstaging of locally advanced breast cancer to facilitate breast conservation, to in vivo drug-sensitivity testing. The pattern of response to NST is used to tailor systemic and locoregional treatment, that is, to escalate treatment in nonresponders and de-escalate treatment in responders. Here we discuss four questions that guide our current thinking about ‘response-adjusted’ surgery of the breast after NST. (i) What critical diagnostic outcome measures should be used when analyzing diagnostic tools to identify patients with pathologic complete response (pCR) after NST? (ii) How can we assess response with the least morbidity and best accuracy possible? (iii) What oncological consequences may ensue if we rely on a nonsurgical-generated diagnosis of, for example, minimally invasive biopsy proven pCR, knowing that we may miss minimal residual disease in some cases? (iv) How should we design clinical trials on de-escalation of surgical treatment after NST? | ||
| 650 | 4 | |a breast cancer | |
| 650 | 4 | |a individualized treatment | |
| 650 | 4 | |a neoadjuvant systemic therapy | |
| 650 | 4 | |a oncology | |
| 650 | 4 | |a surgery | |
| 700 | 1 | |a Sinn, Peter |d 1957- |e VerfasserIn |0 (DE-588)1022590944 |0 (DE-627)717004783 |0 (DE-576)365646342 |4 aut | |
| 700 | 1 | |a Golatta, Michael |d 1974- |e VerfasserIn |0 (DE-588)132350386 |0 (DE-627)521535727 |0 (DE-576)299091392 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Annals of oncology |d Amsterdam [u.a.] : Elsevier, 1990 |g 31(2020), 1, Seite 61-71 |h Online-Ressource |w (DE-627)320428796 |w (DE-600)2003498-2 |w (DE-576)098134345 |x 1569-8041 |7 nnas |a Eliminating the breast cancer surgery paradigm after neoadjuvant systemic therapy current evidence and future challenges |
| 773 | 1 | 8 | |g volume:31 |g year:2020 |g number:1 |g pages:61-71 |g extent:11 |a Eliminating the breast cancer surgery paradigm after neoadjuvant systemic therapy current evidence and future challenges |
| 787 | 0 | 8 | |i Kommentar in |a Heil, Jörg, 1978 - |t Patients should be the tipping point of individualizing breast cancer surgery |d 2020 |w (DE-627)1733331735 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.annonc.2019.10.012 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u http://www.sciencedirect.com/science/article/pii/S0923753419354675 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20200331 | ||
| 993 | |a Article | ||
| 994 | |a 2020 | ||
| 998 | |g 132350386 |a Golatta, Michael |m 132350386:Golatta, Michael |d 910000 |d 910400 |e 910000PG132350386 |e 910400PG132350386 |k 0/910000/ |k 1/910000/910400/ |p 6 | ||
| 998 | |g 1022590944 |a Sinn, Peter |m 1022590944:Sinn, Peter |d 910000 |d 912000 |e 910000PS1022590944 |e 912000PS1022590944 |k 0/910000/ |k 1/910000/912000/ |p 5 | ||
| 998 | |g 132580187 |a Heil, Jörg |m 132580187:Heil, Jörg |d 910000 |d 910400 |e 910000PH132580187 |e 910400PH132580187 |k 0/910000/ |k 1/910000/910400/ |p 1 |x j | ||
| 999 | |a KXP-PPN1693627698 |e 3616516544 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"title":[{"title":"Eliminating the breast cancer surgery paradigm after neoadjuvant systemic therapy","subtitle":"current evidence and future challenges","title_sort":"Eliminating the breast cancer surgery paradigm after neoadjuvant systemic therapy"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"language":["eng"],"relHost":[{"recId":"320428796","part":{"issue":"1","pages":"61-71","extent":"11","volume":"31","text":"31(2020), 1, Seite 61-71","year":"2020"},"id":{"issn":["1569-8041"],"zdb":["2003498-2"],"eki":["320428796"]},"origin":[{"dateIssuedKey":"1990","publisher":"Elsevier ; Kluwer ; Oxford Univ. Press","publisherPlace":"Amsterdam [u.a.] ; Dordrecht [u.a.] ; Oxford","dateIssuedDisp":"1990-"}],"physDesc":[{"extent":"Online-Ressource"}],"disp":"Eliminating the breast cancer surgery paradigm after neoadjuvant systemic therapy current evidence and future challengesAnnals of oncology","pubHistory":["1.1990 -"],"title":[{"title":"Annals of oncology","subtitle":"official journal of the European Society for Medical Oncology","title_sort":"Annals of oncology"}],"corporate":[{"role":"isb","display":"European Society for Medical Oncology"}],"note":["Gesehen am 12.11.20","Ungezählte Beil.: Supplement"],"language":["eng"],"type":{"bibl":"periodical","media":"Online-Ressource"}}],"note":["Gesehen am 31.03.2020"],"recId":"1693627698","person":[{"given":"Jörg","display":"Heil, Jörg","family":"Heil","role":"aut"},{"display":"Sinn, Peter","given":"Peter","role":"aut","family":"Sinn"},{"display":"Golatta, Michael","given":"Michael","role":"aut","family":"Golatta"}],"name":{"displayForm":["J. Heil, H.M. Kuerer, A. Pfob, G. Rauch, H.P. Sinn, M. Golatta, G.J. Liefers & M.J. Vrancken Peeters"]},"id":{"eki":["1693627698"],"doi":["10.1016/j.annonc.2019.10.012"]},"physDesc":[{"extent":"11 S."}],"origin":[{"dateIssuedDisp":"6 January 2020","dateIssuedKey":"2020"}]} | ||
| SRT | |a HEILJOERGSELIMINATIN6202 | ||